Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bryce

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 1, 1991
Medicare on the ropesG K Bryce
Research in Science Education|January 10, 2022
When Is an Interview an Inter View? The Historical and Recent Development of Methodologies Used to Investigate Children's Astronomy KnowledgeEric J Blown, Tom G K Bryce
Current Psychology (New Brunswick, N.J.)|June 26, 2023
Ausubel's <i>meaningful learning</i> re-visitedT G K Bryce, E J Blown
Faraday Discussions|March 4, 2006
Nanoscale aryleneethynylene oligomers incorporating fluorenone units as electron-dopable molecular wiresChangsheng Wang, Andrei S Batsanov, Martin K Bryce
Journal of the Royal Society of Medicine|February 29, 2000
Systemic vasculitis with multiple aneurysms complicating systemic lupus erythematosusR Stratton, K Bryce, H Beynon, et al.
Applied Microbiology and Biotechnology|September 10, 2020
Influence of probiotics on biofilm formation and diversity of bacteria colonising crop sorghum ensiled with unsalable vegetablesDaniel L Forwood, Elizabeth K Bryce, Eleonora Caro, et al.
Regulatory Peptides|August 27, 1996
Design of novel cholecystokinin-B receptor ligands based on the 'double-ring system' approachJ A Lowe, W Qian, S McLean, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel mu opioid receptor ligandsM P Allen, J F Blake, D K Bryce, et al.
Regulatory Peptides|July 2, 1993
CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptorS McLean, R M Snider, M C Desai, et al.
Journal of Medicinal Chemistry|October 28, 1994
5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonistsJ A Lowe, D L Hageman, S E Drozda, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 1, 1991
Medicare on the ropesG K Bryce
Research in Science Education|January 10, 2022
When Is an Interview an Inter View? The Historical and Recent Development of Methodologies Used to Investigate Children's Astronomy KnowledgeEric J Blown, Tom G K Bryce
Current Psychology (New Brunswick, N.J.)|June 26, 2023
Ausubel's <i>meaningful learning</i> re-visitedT G K Bryce, E J Blown
Faraday Discussions|March 4, 2006
Nanoscale aryleneethynylene oligomers incorporating fluorenone units as electron-dopable molecular wiresChangsheng Wang, Andrei S Batsanov, Martin K Bryce
Journal of the Royal Society of Medicine|February 29, 2000
Systemic vasculitis with multiple aneurysms complicating systemic lupus erythematosusR Stratton, K Bryce, H Beynon, et al.
Applied Microbiology and Biotechnology|September 10, 2020
Influence of probiotics on biofilm formation and diversity of bacteria colonising crop sorghum ensiled with unsalable vegetablesDaniel L Forwood, Elizabeth K Bryce, Eleonora Caro, et al.
Regulatory Peptides|August 27, 1996
Design of novel cholecystokinin-B receptor ligands based on the 'double-ring system' approachJ A Lowe, W Qian, S McLean, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel mu opioid receptor ligandsM P Allen, J F Blake, D K Bryce, et al.
Regulatory Peptides|July 2, 1993
CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptorS McLean, R M Snider, M C Desai, et al.
Journal of Medicinal Chemistry|October 28, 1994
5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonistsJ A Lowe, D L Hageman, S E Drozda, et al.
Pageof 3